Role of nitric oxide in Sjogren's syndrome

Arthritis and Rheumatism

Volumn 40, Issue 5, 1997, Pages 875-883

  Konttinen, Yrjö T ^a,d   Platts, Louise A M ^b   Tuominen, Susanne ^c   Eklund, Kari K ^c   Santavirta, Nina ^c   Törnwall, Jyrki ^c   Sorsa, Timo ^c   Hukkanen, Mika ^b   Polak, Julia M ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ACINAR CELL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; NERVE FIBER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; SALIVARY GLAND; SJOEGREN SYNDROME;

EID: 0030993704     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400515     Document Type: Article

References (48)

1. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993
2. Marletta MA: Nitric oxide synthase: aspects concerning structure and catalysis. Cell 23:927-930, 1994
3. Nathan C, Xie Q: Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918, 1994
4. Schmidt HH, Walter U: NO at work. Cell 78:919-925, 1994
5. Stamler JS: Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936, 1994
6. Declaration of Helsinki, Hong Kong amendment, September 1989
7. Malmström MJ, Segerberg-Konttinen M, Tuominen TS, Hietanen JH, Wolf JE, Sane JI, Konttinen YT: Xerostomia due to Sjögren's syndrome: diagnostic criteria, treatment and outlines for a continuous dental care programme and an open trial with Sulfarlem®. Scand J Rheumatol 17:77-86, 1988
8. Törnwall J, Konttinen YT, Hietanen J, Sorsa T, Hukkanen M, Uusitalo H: VIP in salivary glands in Sjögren's syndrome. Br J Rheumatol 34:891-893, 1995
9. Kariologiska principer: Nordisk Lärobok i Kariologi. Fifth edition. Edited by Y Ericsson. Stockholm, Tandläkarförlaget, 1980
10. Lindhe J, editor: Textbook of Clinical Periodontology. Second edition. Copenhagen, Munksgaard, 1989
11. Ainamo J, Bay I: Problems and proposals for recording gingivitis and plaque. Int Dent J 25:229-235, 1975
12. Björby A, Löe H: The relative significance of different local factors in the initiation and development of periodontal inflammation. J Periodontal Res 1:76-77, 1967
13. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J: Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J 32:281-291, 1982
14. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiødt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P: Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347, 1993
15. Greenspan JS, Daniels TE, Talal N, Sylvester RA: The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 37:217-229, 1974
16. Jenkins CD, Zyzanski SJ, Rosenman RH: Progress toward validation of a computer-scored test for the type A coronary-prone behavior pattern. Psychosom Med 33:193-202, 1971
17. Snedecor GW, Cochran WG: Statistical Methods. Seventh edition. Ames, The Iowa State University Press, 1980
18. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activation cytokines and evidence for independent production. J Immunol 141:2407-2412, 1988
19. Hope BT, Michael GJ, Knigge KM, Vincent SR: Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A 88:2811-2814, 1991
20. Wharton J, Polak JM, Gordon L, Banner NR, Springall DR, Rose M, Khagani A, Wallwork J, Yacoub MH: Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res 66:900-912, 1990
21. Springall DR, Riveros-Moreno V, Buttery L, Suburo A, Bishop AE, Merrett M, Moncada S, Polak JM: Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 98:259-266, 1992
22. Pollock JS, Nakane M, Buttery LDK, Martinez A, Springall DR, Polak JM, Förstermann U, Murad F: Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265:C1379-C1387, 1993
23. Hevel JM, White KA, Marletta MA: Purification of the inducible murine macrophage nitric oxide synthase: identification as a flavoprotein. J Biol Chem 266:22789-22791, 1991
24. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM: Induction of nitric oxide synthase in asthma. Lancet 342:1510-1513, 1993
25. Buttery LDK, Evans TJ, Springall DR, Carpenter A, Cohen J, Polak JM: Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest 71:755-764, 1994
26. Buttery LDK, Springall DR, Chester AH, Evans TJ, Standfield N, Parums DV, Yacoub MH, Polak JM: Inducible NO synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrate. Lab Invest 75:77-85, 1996
27. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
28. Konttinen YT, Hukkanen M, Kemppinen P, Segerberg M, Sorsa T, Malmström M, Rose S, Itescu S, Polak JM: Peptide-containing nerves in labial salivary glands in Sjögren's syndrome. Arthritis Rheum 35:815-820, 1992
29. Konttinen YT, Sorsa T, Hukkanen M, Segerberg M, Kuhlefelt-Sundström M, Malmström M, Polak JM: Topology of innervation of labial salivary glands by protein gene product 9.5 and synaptophysin immunoreactive nerves in patients with Sjögren's syndrome. J Rheumatol 19:30-37, 1992
30. Brenneman DE, Eiden LE: Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci U S A 83:1159-1162, 1986
31. Fatatis A, Holtzclaw LA, Avidor R, Brenneman DE, Russell JT: Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with α-adrenergic receptors. Proc Natl Acad Sci U S A 91:2036-2040, 1994
32. Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, Sorsa T, Pertovaara A, Polak JM: Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum 37:965-982, 1994
33. Bodis S, Haregewoin A: Evidence for the release and possible neural regulation of nitric oxide in human saliva. Biochem Biophys Res Commun 194:347-350, 1993
34. Lohinai Z, Szekely AD, Soos L, Feher E: Distribution of nitric oxide synthase containing elements in the feline submandibular gland. Neurosci Lett 192:9-12, 1995
35. Damas J: Pilocarpine-induced salivary secretion, kinin system and nitric oxide in rats. Arch Int Physiol Biochim Biophys 102:103-105, 1994
36. Modin A: Non-adrenergic, non-cholinergic vascular control with reference to neuropeptidc Y, vasoactive intestinal polypeptide and nitric oxide. Acta Physiol Scand 622 (Suppl):1-74, 1994
37. Modin A, Weitzberg E, Lundberg JM: Nitric oxide regulates peptide release from parasympathctic nerves and vascular reactivity to vasoactive intestinal polypeptide in vivo. Eur J Pharmacol 261:185-197, 1994
38. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A: Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167:1358-1363, 1993
39. Padgett EL, Pruett SB: Evaluation of nitrite production by human macrophages. Biochem Biophys Res Commun 186:775-781, 1992
40. Curran RD, Billiar TR, Stuchr DJ, Ochoa JB, Harbrecht BG, Flint SG, Simmons RL: Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 212:462-471, 1990
41. Liew FY, Li Y, Millott S: Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145:4306-4310, 1990
42. Syed MA, Leong SK, Chan AS: Localization of NADPH-diaphorase reactivity in the chick and mouse thyroid gland. Thyroid 4:475-478, 1994
43. Fox RI, Kang HI, Ando D, Abrams J, Pisa E: Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152:5532-5539, 1994
44. Ogawa N, Dang H, Talal N: PCR analysis of cytokines produced in salivary glands of Sjögren's syndrome patients. In, Sjögren's Syndrome: State of the Art. Edited by M Homma, S Sugai, T Tojo, N Miyasaka, M Akizuki. Amsterdam, Kugler Publications, 1994
45. Boumba D, Skopouli FN, Moutsopoulos HM: Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 34:326-333, 1995
46. Segerberg-Konttinen M, Konttinen YT, Bergroth V: Focus score in the diagnosis of Sjögren's syndrome. Scand J Rheumatol Suppl 61:47-51, 1986
47. Segerberg-Konttinen M: Focal adenitis in lacrimal and salivary glands: a post-mortem study. Scand J Rheumatol 17:379-385, 1988
48. Dale AC: Salivary glands. In, Oral Histology: Development, Structure, and Function. Fourth edition. Edited by AR Ten Gate. St. Louis, Mosby, 1994